These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16681595)

  • 1. A homozygous missense mutation in PEPD encoding peptidase D causes prolidase deficiency associated with hyper-IgE syndrome.
    Hershkovitz T; Hassoun G; Indelman M; Shlush LI; Bergman R; Pollack S; Sprecher E
    Clin Exp Dermatol; 2006 May; 31(3):435-40. PubMed ID: 16681595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of prolidase (peptidase D) deficiency.
    Endo F; Matsuda I
    Mol Biol Med; 1991 Feb; 8(1):117-27. PubMed ID: 1943683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single nucleotide change in the prolidase gene in fibroblasts from two patients with polypeptide positive prolidase deficiency. Expression of the mutant enzyme in NIH 3T3 cells.
    Tanoue A; Endo F; Kitano A; Matsuda I
    J Clin Invest; 1990 Jul; 86(1):351-5. PubMed ID: 2365824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular defect in siblings with prolidase deficiency and absence or presence of clinical symptoms. A 0.8-kb deletion with breakpoints at the short, direct repeat in the PEPD gene and synthesis of abnormal messenger RNA and inactive polypeptide.
    Tanoue A; Endo F; Akaboshi I; Oono T; Arata J; Matsuda I
    J Clin Invest; 1991 Apr; 87(4):1171-6. PubMed ID: 2010534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel nonsense mutation of the PEPD gene in a Japanese patient with prolidase deficiency.
    Kikuchi S; Tanoue A; Endo F; Wakasugi S; Matsuo N; Tsujimoto G
    J Hum Genet; 2000; 45(2):102-4. PubMed ID: 10721675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family.
    Lupi A; Rossi A; Campari E; Pecora F; Lund AM; Elcioglu NH; Gultepe M; Di Rocco M; Cetta G; Forlino A
    J Med Genet; 2006 Dec; 43(12):e58. PubMed ID: 17142620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of five new patients affected by prolidase deficiency: the lack of enzyme activity causes necrosis-like cell death in cultured fibroblasts.
    Forlino A; Lupi A; Vaghi P; Icaro Cornaglia A; Calligaro A; Campari E; Cetta G
    Hum Genet; 2002 Oct; 111(4-5):314-22. PubMed ID: 12384772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A broad spectrum of developmental delay in a large cohort of prolidase deficiency patients demonstrates marked interfamilial and intrafamilial phenotypic variability.
    Falik-Zaccai TC; Khayat M; Luder A; Frenkel P; Magen D; Brik R; Gershoni-Baruch R; Mandel H
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):46-56. PubMed ID: 19308961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene, in hyper-IgE syndrome.
    Papanastasiou AD; Mantagos S; Papanastasiou DA; Zarkadis IK
    Mol Immunol; 2010 Apr; 47(7-8):1629-34. PubMed ID: 20149460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups.
    Jiao H; Tóth B; Erdos M; Fransson I; Rákóczi E; Balogh I; Magyarics Z; Dérfalvi B; Csorba G; Szaflarska A; Megarbane A; Akatcherian C; Dbaibo G; Rajnavölgyi E; Hammarström L; Kere J; Lefranc G; Maródi L
    Mol Immunol; 2008 Nov; 46(1):202-6. PubMed ID: 18706697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonsense mutation of PEPD in four Amish children with prolidase deficiency.
    Wang H; Kurien BT; Lundgren D; Patel NC; Kaufman KM; Miller DL; Porter AC; D'Souza A; Nye L; Tumbush J; Hupertz V; Kerr DS; Kurono S; Matsumoto H; Scofield RH
    Am J Med Genet A; 2006 Mar; 140(6):580-5. PubMed ID: 16470701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship.
    Lupi A; De Riso A; Torre SD; Rossi A; Campari E; Vilarinho L; Cetta G; Forlino A
    J Hum Genet; 2004; 49(9):500-506. PubMed ID: 15309682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation.
    Bittner TC; Pannicke U; Renner ED; Notheis G; Hoffmann F; Belohradsky BH; Wintergerst U; Hauser M; Klein B; Schwarz K; Schmid I; Albert MH
    Klin Padiatr; 2010 Nov; 222(6):351-5. PubMed ID: 21058221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls of homozygosity mapping: an extended consanguineous Bardet-Biedl syndrome family with two mutant genes (BBS2, BBS10), three mutations, but no triallelism.
    Laurier V; Stoetzel C; Muller J; Thibault C; Corbani S; Jalkh N; Salem N; Chouery E; Poch O; Licaire S; Danse JM; Amati-Bonneau P; Bonneau D; Mégarbané A; Mandel JL; Dollfus H
    Eur J Hum Genet; 2006 Nov; 14(11):1195-203. PubMed ID: 16823392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations.
    Lupi A; Tenni R; Rossi A; Cetta G; Forlino A
    Amino Acids; 2008 Nov; 35(4):739-52. PubMed ID: 18340504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations.
    Freeman AF; Domingo DL; Holland SM
    Oral Dis; 2009 Jan; 15(1):2-7. PubMed ID: 19036057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal recessive prolidase deficiency. Three patients with recalcitrant ulcers.
    Ogata A; Tanaka S; Tomoda T; Murayama E; Endo F; Kikuchi I
    Arch Dermatol; 1981 Nov; 117(11):689-97. PubMed ID: 7316526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of prolidase deficiency in fibroblasts using adenovirus mediated gene transfer.
    Ikeda K; Tohyama J; Tsujino S; Sato K; Oono T; Arata J; Endo F; Sakuragawa N
    Jpn J Hum Genet; 1997 Sep; 42(3):401-8. PubMed ID: 12503186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of prolidase as an enzyme participating in the metabolism of collagen.
    Pałka JA
    Rocz Akad Med Bialymst; 1996; 41(2):149-60. PubMed ID: 9020526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.